top of page

COLL

Collegium Pharmaceutical

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$106.7 M

Burn Rate (Qtr)

$25.3M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

COLL

BPIQ_Logo_RGB-01.jpg

Company Profile

Collegium Pharmaceutical is a specialty pharmaceutical company committed to being the leader in responsible pain management. For nearly two decades, Collegium has been focused on developing and commercializing new medicines for pain management that reflect our Core Values and our commitment to people suffering from pain, providers and our communities. The result of those efforts is a portfolio of meaningfully differentiated medications to treat moderate to severe pain.

Recent Posts

See what the community is saying - click to see full post.

Smid-cap Biopahrma M&A activity - Q1 '23 Biggest Quarter in Years!

Smid-cap Biopahrma M&A activity - Q1 '23 Biggest Quarter in Years!

Smid-cap Biopahrma M&A activity - So Far a Huge Q1 '23

Smid-cap Biopahrma M&A activity - Big Beginning to 2023!

Smid-cap Biopahrma M&A activity - December to Close Out the Year with a Bang!

Smid-cap Biopahrma M&A activity - Big Acquisition Announcements and Rumors in November!

bottom of page